Skip to content

Study of Health Behavior in Patients After Heart Valve Replacement: Longitudinal Studies

Study on the Influencing Factors and the Pathways of Health Behavior in Patients After Heart Valve Replacement

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06490952
Enrollment
219
Registered
2024-07-08
Start date
2024-01-01
Completion date
2024-12-01
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Behavior, Heart Valve Diseases, Postoperative Period

Brief summary

To investigates the influencing factors and the pathways of health behavior in patients after heart valve replacement.

Detailed description

Currently, the prevalence of heart valve disease is 2.0% to 13.2%, and heart valve replacement is the most important treatment to address heart valve disease. Heart valve replacement surgery is highly traumatic and risky, and the recovery of physiological, psychological, and social functions of postoperative patients is challenging, affecting the recovery process of patients. Healthy behavior is a lifestyle that can effectively reduce risk factors for adverse events and complications at the physiological, psychological, and social levels to slow disease progression, which can help promote patient recovery and improve prognosis. Therefore, this study investigates and analyzes the health behaviors of postoperative patients in different periods, explores their influencing factors and analyzes their pathways of action.

Interventions

None listed

Sponsors

Fujian Medical University Union Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years; 2. VHD diagnosed by echocardiography; 3. Received HVR treatment; 4. able to communicate normally.

Exclusion criteria

1. Those with a conscious disorder or mental illness; 2. Those with severe organic diseases or comorbidities; 3. Those with cardiac function class IV; 4. Those who could not complete the questionnaire correctly independently or under the guidance of the researcher.

Design outcomes

Primary

MeasureTime frameDescription
Health behaviorAt 1-2 days before discharge, at 1 month after discharge, at 3 month after discharge, at 6 month after discharge.A set of behavioral activities undertaken by an individual to promote or maintain health.

Secondary

MeasureTime frameDescription
Social supportAt 1-2 days before discharge, at 1 month after discharge, at 3 month after discharge, at 6 month after discharge.Support received by an individual from within a social relationship.
Anxiety and depressionAt 1-2 days before discharge, at 1 month after discharge, at 3 month after discharge, at 6 month after discharge.Measuring the psychological situation.
Self-efficacyAt 1-2 days before discharge, at 1 month after discharge, at 3 month after discharge, at 6 month after discharge.Measure the level of self-confidence.
Medication LiteracyAt 1-2 days before discharge, at 1 month after discharge, at 3 month after discharge, at 6 month after discharge.Measuring medication-taking skills.

Countries

China

Contacts

Primary ContactYanjuan Lin
fjxhyjl@163.com+86 591 8621 8336

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026